Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Parra

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Actas Urologicas Espanolas|March 1, 1990
[Neoplasm invasion of the renal vein by transitional cell carcinoma of the kidney pelvis]F J Calahorra Fernández, C Pérez-Seoane, A Rodríguez Antolin, et al.
International Journal of Pharmaceutics|November 20, 2009
Bicellar systems for in vitro percutaneous absorption of diclofenacL Rubio, C Alonso, G Rodríguez, et al.
Archivos Espanoles De Urologia|July 1, 1989
[Primary embryonic rhabdomyosarcoma of the prostate. An unusual location]M Romero Tenorio, J M Fariñas Varo, J M Báez Perea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophagesI Huber-Ruano, C Raventós, I Cuartas, et al.
International Journal of Cosmetic Science|March 11, 2009
Physico-chemical modifications of liposome structures through interaction with surfactantsyI Ribosa, M T Garcia, J L Parra, et al.
Actas Urologicas Espanolas|January 1, 1987
[Carcinoma of the renal pelvis]J Extramiana Cameno, F De la Rosa, F J Calahorra, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 11, 2013
Bicellar systems as vehicle for the treatment of impaired skinL Rubio, C Alonso, G Rodríguez, et al.
International Journal of Pharmaceutics|January 30, 2013
Bicellar systems as new delivery strategy for topical application of flufenamic acidL Rubio, C Alonso, G Rodríguez, et al.
Oncogene|December 9, 2008
Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicityM Scaltriti, C Verma, M Guzman, et al.
Oncogene|May 30, 2012
A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancersB Morancho, J L Parra-Palau, Y H Ibrahim, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Actas Urologicas Espanolas|March 1, 1990
[Neoplasm invasion of the renal vein by transitional cell carcinoma of the kidney pelvis]F J Calahorra Fernández, C Pérez-Seoane, A Rodríguez Antolin, et al.
International Journal of Pharmaceutics|November 20, 2009
Bicellar systems for in vitro percutaneous absorption of diclofenacL Rubio, C Alonso, G Rodríguez, et al.
Archivos Espanoles De Urologia|July 1, 1989
[Primary embryonic rhabdomyosarcoma of the prostate. An unusual location]M Romero Tenorio, J M Fariñas Varo, J M Báez Perea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
An antisense oligonucleotide targeting TGF-β2 inhibits lung metastasis and induces CD86 expression in tumor-associated macrophagesI Huber-Ruano, C Raventós, I Cuartas, et al.
International Journal of Cosmetic Science|March 11, 2009
Physico-chemical modifications of liposome structures through interaction with surfactantsyI Ribosa, M T Garcia, J L Parra, et al.
Actas Urologicas Espanolas|January 1, 1987
[Carcinoma of the renal pelvis]J Extramiana Cameno, F De la Rosa, F J Calahorra, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|June 11, 2013
Bicellar systems as vehicle for the treatment of impaired skinL Rubio, C Alonso, G Rodríguez, et al.
International Journal of Pharmaceutics|January 30, 2013
Bicellar systems as new delivery strategy for topical application of flufenamic acidL Rubio, C Alonso, G Rodríguez, et al.
Oncogene|December 9, 2008
Lapatinib, a HER2 tyrosine kinase inhibitor, induces stabilization and accumulation of HER2 and potentiates trastuzumab-dependent cell cytotoxicityM Scaltriti, C Verma, M Guzman, et al.
Oncogene|May 30, 2012
A dominant-negative N-terminal fragment of HER2 frequently expressed in breast cancersB Morancho, J L Parra-Palau, Y H Ibrahim, et al.
Pageof 9